Retinal Function in Diabetic Patients Without Retinopathy
- Conditions
- Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
- Registration Number
- NCT00839150
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Brief Summary
The primary purpose was to assess, in diabetic patients without diabetic retinopathy and control subjects, color vision, contrast sensitivity, electroretinography, and flicker-induced vasodilatation using the Dynamic Vessel Analyzer, in order to specify the earliest impaired retinal cells in diabetes, and gain more insight into diabetic retinopathy pathogenesis.
- Detailed Description
Type 1 and type 2 diabetic patients with no diabetic retinopathy and no hypertension were compared with sex and age-matched control subjects. Color vision was tested with the desaturated LANTHONY 15-Hue test. Contrast sensitivity was assessed with the Pelli-Robson contrast sensitivity test. Pattern-electroretinogram, Ganzfeld full-field electroretinogram and multifocal electroretinogram were recorded according to the International Society for Clinical Electrophysiology of Vision (ISCEV). Flicker-induced vasodilatation in retinal arteries and veins was assessed using the Dynamic Vessel Analyzer.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 56
-
For diabetic patients :
- age between 20 and 55
- type 1 or type 2 diabetes mellitus
- diabetes duration of more than 5 years
- no diabetic retinopathy on fundus examination or fundus photographs
-
For control subjects :
- sex and age matching with the diabetic patients
- no diabetes, no familial or personal history of elevated blood sugar
*For both diabetic patients and control subjects :
- presence of cataract or history of cataract surgery
- intraocular pressure of more than 21 mmHg
- abnormal score on the Ishihara test
- other ocular disease
- ametropia more than 3 diopters, anisometropia more than 1 diopter, astigmatism more than 1 diopter
- systemic hypertension (defined as systolic blood pressure > 140 mmHg, diastolic blood pressure > 90 mmHg)
- treatment with vasoactive drugs
- tobacco consumption of more than 20 cigarettes a day
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hopital Lariboisiere
🇫🇷Paris, France